Singapore markets closed

NeuBase Therapeutics, Inc. (NBSE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.0000+0.2400 (+8.70%)
At close: 04:00PM EST
3.2700 +0.27 (+9.00%)
After hours: 04:17PM EST
Sign in to post a message.
  • G
    Gator
    Nice little Green day and many more to come. As the stock market is taking a breather.
  • J
    Julio
    What's the news?

    Acting like something is in the works. Not complaining.
  • T
    Thanos-a-diol
    following NeuBase for the CSO transfer from ArrowHead.
  • d
    damien
    pps going to keep trending upwards?
  • P
    Patton is Fueled Up
    Why????
  • M
    Manuel
    looks like I'm the only excited one today!
  • P
    PK
    I bought more today. I'm in for long play.
  • F
    Frank
    interesting stock action on volume today, apparently based on approval of another company's drug. Make sense?

    NeuBase Therapeutics up 30% on Alnylam approval
    Nov. 20, 2019 2:57 PM ET|About: NeuBase Therapeutics, Inc. (NBSE)|

    The FDA earlier approved Alnylam's Givlaari for acute hepatic porphyria. It's reported to be priced at $575K annually.

    NeuBase (NBSE +30.7%) has similar technology. David Einhorn's Greenlight Capital (GLRE -1.9%) earlier this year reported a stake in the company.
  • P
    PK
    I'm here. Love this quiet board.
  • S
    Stock
    NBSE 10$+ Coming
  • c
    cem
    long
  • T
    Techfan20
    Up on a down day. Very interesting.
  • D
    Dobi
    OH FINALLY :D
  • F
    Frank
    NeuBase Therapeutics (NASDAQ:NBSE) is building on a strong gain today, up 5.2% after hours as it gets an initiation at Outperform by Oppenheimer.

    The firm set its price target to $14 (in line with other Street targets), implying $122 upside from today's close.

    NeuBase closed up 25.2% today in apparent sympathy with Alnylam, which has similar technology and saw FDA approval of its Givlaari for acute hepatic porphyria.
  • J
    Jose Miguel
    Is this getting expensive? Looks like nothing’s even in phase 1 trials yet, with cash on hand under $5MM (according to morningstar). All that aside, absolute bio rockstars running the show here. Could be a massive, massive winner in 2020. Could also be got for cheaper than it is today. Good longterm prospects either way
  • P
    PK
    I've been buying this 7 and selling @ 10 for a year over and over.

    Actually thinking about not selling this time.
  • P
    PK
    thinking about adding more here after Christmas.
  • P
    PK
    I just keep adding shares of this stock.
  • s
    samrat
    when can we start trading in Robinhood
  • T
    Toby
    S3 Filing. Prep for BD deal?